title: Combining systemic bisphosphonates with palliative external beam radiotherapy or bone-targeted radionuclide therapy: interactions and effectiveness.
authors.forename: V
authors.initials: V
authors.lastname: Vassiliou
authors.forename: O
authors.initials: O
authors.lastname: Bruland
authors.forename: N
authors.initials: N
authors.lastname: Janjan
authors.forename: S
authors.initials: S
authors.lastname: Lutz
authors.forename: D
authors.initials: D
authors.lastname: Kardamakis
authors.forename: P
authors.initials: P
authors.lastname: Hoskin
mesh_terms: D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000556:secondary / Q000628:therapy; D003131:Combined Modality Therapy; D004164:Diphosphonates / Q000627:therapeutic use*; D006801:Humans; D010166:Palliative Care / Q000379:methods; D016499:Radioimmunotherapy / Q000379:methods*; D011868:Radioisotopes / Q000627:therapeutic use
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D011868:Radioisotopes